(EN) The present invention is directed to a new class of 4-sulfanimide-quinoline derivatives and to their use as NMDA antagonists.(FR) L'invention se rapporte à une nouvelle catégorie de dérivés de 4-sulfanimide-quinoléine et à leur utilisation comme antagonistes de NMDA.
NMDA antagonists
申请人:Merrell Pharmaceuticals Inc.
公开号:US05606063A1
公开(公告)日:1997-02-25
The present invention is directed to a new class of 4-sulfanimide-quinoline derivatives and to their use as NMDA antagonists.